Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4743
Abstract: Sunitinib is one of the first‐line targeted drugs for metastatic renal cell carcinoma (RCC) with dual effects of antiangiogensis and proapoptosis. Sam68 (Src‐associated in mitosis, 68 KDa), is found being involved in cell apoptosis. This…
read more here.
Keywords:
sam68 expression;
cell;
apoptosis;
sunitinib ... See more keywords